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ABSTRACT By the use of x-ray structures and ﬂexible docking, we have developed the ﬁrst in silico ligand-based view of the
structural determinants of the binding of small molecule mimics of gelsolin, natural products bound to actin. Our technique
highlights those residues on the actin binding site forming important hydrophobic and hydrogen-bonding interactions with the
ligands. Signiﬁcantly, through the ﬂexible docking of toxin fragments, we have also identiﬁed potential residues on the actin
binding site that have yet to be exploited. Guided by these observations, we have demonstrated that kabiramide C can be
modiﬁed to produce a structure with a predicted binding energy increased by 20% while the molecular mass is reduced by 20%,
clearly indicating the potential for future elaboration of structures targeting this important component of the cytoskeleton.
INTRODUCTION
Actin is a major component of the cytoskeleton in eukaryotes,
responsible for many important cellular functions such as
shape, motility, division, and adhesion (1). Apart from its
intrinsic cell biological interest, it therefore makes an attrac-
tive target for cancer research. Several natural product toxins,
mainly derived from marine life, have been shown to target
actin and to display potent antitumor activity (2). Intrigu-
ingly, there is increasing evidence these molecules target the
same binding site as, and mimic the interactions of, actin
binding proteins such as gelsolin, an F-actin capping and sev-
ering protein (3–5). Thus, elucidating the structural basis for
the binding of these macrolides is of great cross-disciplinary
interest (6–9). Several crystal structures of toxins bound to
actin have been deposited in the Protein Data Bank in recent
years (Fig. 1): kabiramide C (1QZ5) (3), jaspisamide A
(1QZ6) (3), ulapualide A (1S22) (10), swinholide A (1YXQ)
(11), reidispongiolide A (2ASM) (12), sphinxolide B (2ASO)
(12), reidispongiolide C (2ASP) (12), aplyronine A (1WUA)
(13), and bistramide A (2FXU) (14). The relatively large size
and complexity of these toxins means that a large number of
residues has been implicated in their binding, and uniﬁed
views of the binding requirements of these structures have
begun to appear. As the amount of available data grows, an in
silico approach to rationalize the available structural data on
protein-ligand bindingmay now be feasible and perhaps even
necessary to take advantage of the data to its fullest. In
particular, identifying the most important interactions across
all the structural classes for which x-ray data exist would aid
future synthetic efforts to develop small molecule binders to
actin. Surprisingly, however, no such study has been pub-
lished to date.
Several molecular dynamics (MD) simulations have con-
sidered protein-protein interactions and the dynamics of
actin in its F- and G-forms (15–19); Yamada and co-workers
have derived structure-cytotoxicity relationships for some
derivatives of aplyronine A (20–22). However, no in silico
study of ligands binding to the hydrophobic cleft of G-actin
has been reported. In this work we describe the ﬁrst such
computational investigation, with the aims of identifying the
most important interactions in the hydrophobic binding site
of G-actin, exploring whether there are interactions that have
yet to be identiﬁed and could be exploited by new ligands
and identifying structural elements that can be modiﬁed or
removed to produce more efﬁcient ligands (23) than those
characterized hitherto.
Docking has been widely and successfully used in virtual
screening for drug design (24). It is a computationally cheaper
alternative to MD simulations for determining the binding
properties of a small molecule to a protein receptor. In this
computational technique, the structure of the protein is nor-
mally kept rigid, and combinations of rigid body rotations and
bond torsions in the ligand are sampled, the search being
guided by a heuristic method such as genetic algorithms
(GAs) or simulated annealing. To allow for rapid evaluation
of protein-ligand afﬁnity, force ﬁeld-based energy evalua-
tions are often replaced by empirical equations, known as
scoring functions, where entropic and solvation effects are
accounted for implicitly. Despite being much faster than MD
simulations, docking of large ﬂexible molecules remains
challenging. To circumvent these difﬁculties, in this work we
‘scan’ the actin binding site by means of ﬂexible docking of
smaller substructures (or ‘fragments’) of the macrolides, in
addition to ﬂexible docking of the whole macrolide struc-
tures. This maintains the speed of computation of docking,
allowing us to compute a much larger conﬁgurational space
of the ligands and obviating problems with uncoverged
simulations.
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Nonetheless, by using substructures of macrolides known
to bind to actin, we are able to ensure the relevance of the
resulting interactions, in contrast to the results from more
generalized probes, such as those often used in MD simula-
tions (25). Further, the smaller size of the fragments enables
the exploration of regions of the binding site that are not
accessible to the full macrolide structures, revealing potential
interactions that have yet to be targeted by natural or synthetic
methods. Keeping the protein structure rigid is obviously an
approximation, but a reasonable one in this case, as we shall
show that the relevant region of the binding site does not
demonstrate a large degree of ﬂexibility. A more physically
rigorous method of exploring the binding of macrolides to
actin would be an MD simulation. However, ensuring suf-
ﬁcient convergence of the simulations is challenging, and
running individual simulations for each macrolide is likely to
be computationally prohibitive. Finally, it is not yet possible
to accurately measure binding afﬁnities with the scoring
functions used in docking programs (26). However, neither is
it feasible to compute binding afﬁnities for the wide range of
structures found in macrolides using more rigorous methods
such as free energy perturbation (27), which are capable of
predicting relative afﬁnities only, and only within a series of
structurally similar molecules. Hence, docking is the most
efﬁcient and appropriate means to obtain a semiquantitative
picture of binding.
METHODS
To model actin, we used the x-ray structure of actin bound with swinholide
A (1YXQ). There are no missing atoms in the structure, which aided the
preprocessing step, performed with AutoDock Tools (28,29). All the het-
eroatoms were removed from the structure, and we did not consider the
impact of crystallographic water molecules or metal ions. X-ray coordinates
of all the ligands considered in this study were available in their bound poses
to actin and were therefore aligned with the binding site of 1YXQ by a least
squares ﬁt of the C-a atoms in selected residues of the respective actin
structures. This was accomplished using the Tcl interface in the visual
molecular dynamics (VMD) viewer (30). We used residues 23–25, 116,
133–148, 166–170, and 330–355 for ﬁtting, based on previous reports that
had identiﬁed these residues as important parts of the gelsolin binding site.
The C-a root mean-square deviation (RMSD) for these residues, after
alignment, ranged between 0.28 and 0.46 A˚, indicating no signiﬁcant
induced ﬁt behavior on binding of any of these molecules. We therefore
concluded that the binding site of 1YXQ should provide a suitable receptor
for all the ligands we studied. For processing and modifying the ligands, we
used the molecular modeling package Ghemical 2.01 (http://www.uku.ﬁ/
;thassine/projects/ghemical/) to add hydrogen atoms and, where necessary,
FIGURE 1 Molecular structures of macrolides bistramide A, reidispongiolide A, sphinxolide B, reidispongiolide C (the macrolide tail of reidispongiolide C
differs from that of reidispongiolide A and sphinxolide B in the boxed region), kabiramide C, jaspisamide A, ulapualide A (which share a trisoxazole macrolide
ring), and aplyronine A that bind to the gelsolin binding site on actin.
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brief minimizations of any manually added atoms to generate sensible bond
lengths, constraining the rest of the structure to the x-ray coordinates.
The macrolides shown in Fig. 1 are large, ﬂexible molecules and rep-
resent a challenge to current docking methodologies. To ensure convergence
of the docking, we ran a series of control dockings using the x-ray structures
of selected macrolides, i.e., aplyronine A, bistramide A, kabiramide C,
jaspisamide A, reidispongiolide A, and reidispongiolide C. All of these
compounds had completely deﬁned atomic positions, with the exception of
reidispongiolide C, which has a disordered terminal carboxylate group (but
we did not anticipate that this would have a major effect on the results). The
tail region of ulapualide A was disordered, swinholide A binds as a dimer,
and the crystal structure of sphinxolide B appears to be distorted due to an
interaction with a symmetry-related actin molecule. Therefore these struc-
tures were not used in our benchmarking. We used AutoDock Tools to
determine the number of ﬂexible bonds; this excluded any part of the rings in
the molecule, even though they are likely to be ﬂexible. However, our
attention was focused on the portion of the molecules that occupy the
hydrophobic cleft, which did not include any of the macrolide rings.
Despite the ‘‘anchor’’ portion of the molecules being held rigid, they are
all veryﬂexible by the standardof the ‘drug-like’ or ‘fragment-like’molecules
typically used in docking studies,with the number of torsions ranging from16
in jaspisamide A to 29 in aplyronine A. To ﬁnd a set of parameters adequate
for docking these molecules, we carried out the following protocol: First, as a
control experiment to ensure that the actin binding site is ‘‘dockable’’, we
performed a rigid docking of each x-ray structure into the receptor. For
docking, we used AutoDock 3.0 (31), employing the Lamarckian GA opti-
mizer. Default parameters were used, except that we increased the population
size of the GA to 300 and the number of energy evaluations to 5,000,000 per
GA run. After establishing that the rigid dockings produced acceptable
results, a series of ﬂexible dockings was carried out. Due to the extremely
large search space, we performed several docking runs in parallel, with 20
separate runs, and pooled the results. Previously, we built 49 small molecule
fragments of ulapualide A (andminor structural variations) to probe its action
as a toxin and as a modulator of gene expression (32). We therefore also used
these fragments to ensure the actin binding site was mapped at a sufﬁcient
level of detail. This technique should allow amore exhaustive sampling of the
conﬁgurational space of the docked ligand, compared to using an entire
macrolide structure, while maintaining interactions that are relevant between
the actin binding site and the molecules under study.
Structures of the fragments are given in the Supplementary Material.
Flexible dockings were performed using the same parameters as the rigid
docking, except that we carried out 600 runs. The best docked structures for
each run were collected, and the atoms with the most negative (i.e., most
favorable) van der Waals and electrostatic interactions were extracted and
displayed as clusters of points in VMD, where each cluster represented an
area of the actin binding site into which docked structures were consistently
placed. We selected atoms from each cluster to represent the interaction, and
these were overlaid on the protein-ligand complex for visualization. This
allowed us to identify parts of the actin structure of particular importance for
the binding of the ligands studied, using VMD, MSMS (33), and Persistence
of Vision Raytracer (POV-Ray; http://www.povray.org/).
RESULTS
Before exploring the actin binding site via docking, it was
necessary to conﬁrm that the actin binding site was dockable
using AutoDock. To this end, we rigidly docked the x-ray
structures of six macrolides into the x-ray receptor structure
of 1YXQ. We used default parameters, as the large size of
the ligands, and their lack of ﬂexibility should reduce the
search space considerably. For each of the ligands, the 10
docking runs converged to the same structure within an
RMSD of 0.50 A˚. Compared to the x-ray structures obtained
by superposition of the receptor a carbons, the rigidly
docked structures differed by no more than 1.07 A˚. A typical
result is shown in Fig. 2, where the x-ray coordinates of
kabiramide C after superposition of the C-a carbon atoms of
actin in 1QZ5 and 1YXQ are shown in light shading and
those of the x-ray coordinates after rigid docking to the actin
structure of 1YXQ are in dark shading. The RMSD between
the two structures is 0.71 A˚. An RMSD of 2.0 A˚ is widely
considered to match up important interactions between a
ligand and receptor (34), and given the 0.46 A˚ RMSD
between the C-a atoms of actin in 1YXQ and 1QZ5, this
result suggests that the structures of macrolides can be
redocked successfully to the 1YXQ receptor. Therefore we
proceeded with ﬂexible docking of each of the seven x-ray
structures and the 49 fragments. Subsequently, we exam-
ined the distribution of docking scores contributed by
each atom to identify a cutoff value for visualization.
For the molecules we studied, van der Waals interactions
displayed a wider range of contributions than electrostatic
ones. Given the hydrophobic nature of the binding site, this is
not surprising. Therefore, we retained atoms from any
structure that contributed.0.6 kcal/mol to the docking score
via van der Waals interactions and .0.3 kcal/mol through
electrostatic interactions. Examination of the distribution of
the atoms showed clear clustering; hence we represented each
cluster by a single atom chosen manually from the approx-
imate center of each cluster. The majority of van der Waals
interactions were mediated through contacts between the
receptor atoms and aliphatic and aromatic carbon atoms in the
ligand. Hence, these were classiﬁed as hydrophobic interac-
tions. Favorable electrostatic interactions were mediated
through oxygen and nitrogen atoms and through hydrogen
atoms, the latter attached to oxygen or nitrogen atoms. There-
fore, contacts involving the ﬁrst two atom types are classiﬁed
as hydrogen-bond acceptors, and the latter as hydrogen-bond
donor interactions. The binding site of the natural products
(see Fig. 1) can be split into threemain sections: the hydropho-
bic pocket, where most macrolides have a large hydrophobic
‘anchor’ (except for bistramide A); the hydrophobic ‘cleft’,
where a hydrophobic tail is intercalated and which is
FIGURE 2 Comparison of rigidly docked structure of kabiramide C into
the receptor coordinates of actin in 1YXQ (light shading) against the x-ray
coordinates in 1QZ5 (dark shading), after alignment of C-a carbons in actin.
RMSD between the two kabiramide structures is 0.71 A˚, compared to the
C-a RMSD of 0.41 A˚.
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responsible for the depolymerization effects of the molecules;
and a region at the other end of the cleft, where only bis-
tramide A has been found to bind. We therefore examined
each region in turn for important interactions. The results are
displayed in panels a–c of Fig. 3. Panel d shows the binding
site of kabiramide C in the context of the entire actin structure.
The most important interactions in the hydrophobic
pocket are shown in Fig. 3 a, with the rigidly docked struc-
tures of jaspisamide A (blue) and reidispongiolide A (yellow)
for reference. Hydrophobic interactions are represented by
cyan spheres, hydrogen-bond acceptor interactions are rep-
resented by red spheres, and hydrogen-bond donor sites in-
dicated by blue spheres. For jaspisamide A the hydrophobic
interaction between the trisoxazole rings and Gly-23 (labeled
A) is highlighted. Conversely, the reidispongiolide A ring
occupies hydrophobic interaction B, formed between the
lactone group and a pocket formed of Ala-144, Ser-145, Pro-
332, Arg-335, Ser-338, and Ile-341. No obvious hydrogen-
bond donors exist sufﬁciently close to the carbonyl group
oxygen, so the interaction seems to be entirely hydrophobic.
Indeed, replacing the carbonyl group oxygen with an ethyl-
ene carbon and repeating the rigid docking of reidispongio-
lide A had no deleterious effect on the ﬁnal docked energy;
in fact, the energy became more favorable by0.4 kcal/mol.
Additionally, a hydrogen-bond interaction at Arg-147 is
highlighted (C). These interactions were noted by Allingham
and co-workers (3,12). However, docking also suggested
the possibility of hydrogen-bond donor interactions with
Asp-25 and Glu-334 (D and E). As no macrolide structure
has the necessary donor groups in the right arrangement for
hydrogen-bonding to occur, hitherto these residues have not
been identiﬁed as potentially important.
Fig. 3 b shows the hydrophobic cleft, with the rigidly
docked structures of bistramide A, kabiramide C, and
reidispongiolide A superimposed. Unsurprisingly, the cleft
is dominated by hydrophobic interactions. Important residues
for these interactions include Ile-135, Val-139, Tyr-143, Tyr-
169, Leu-346, and Thr-351. This region of the cleft has been
extensively studied, and these interactions are consistent with
those identiﬁed by Allingham and co-workers (12). How-
ever, we did notice that during ﬂexible docking, more
extensive hydrophobic interactions were formed with Thr-
351 (H) than in the x-ray structures, perhaps due to the fact
that only a methoxy group is substituted at the relevant po-
sition (C32 in kabiramide C and C33 in reidispongiolide A).
Below we investigate the possibility that replacement or
extension of this group with a moderately larger moiety may
increase binding afﬁnity. Two hydrogen-bond interactions
are also indicated in this region (J and K); these positions
would be exposed to solvent and may be useful areas to
introduce polar contacts either for direct hydrogen-bonding
interactions with Thr-351 or Tyr-169 or mediated through
water interactions.
Fig. 3 c shows the enone side chain of bistramide A near
Tyr-169. This is at the opposite end of the hydrophobic cleft
to where all other previously characterized ligands have been
anchored and is therefore of special interest. Kozmin and
co-workers’ description of the binding of bistramide A notes
a high preponderance of polar contacts in this structure and
that the enone side chain is disordered and does not play a
critical role in the binding of bistramide A (14). Therefore, it
is interesting that three hydrophobic interactions are close
to the enone structure, indicating substantial potential for
further structural elaboration of bistramide-based molecules.
These interactions are mediated by Tyr-133 and Val-370
(interaction L), Val-134 (interaction M), Leu-110 (interaction
N), and Leu-136 (interaction I). Interaction I is also close to
Val-139 and Tyr-169. However, the unfavorable electrostatic
interactions are only minor, and the shape of the receptor in
this region provides a strongly favorable van der Waals
FIGURE 3 Predicted important interactions at the gelsolin binding site of
actin. Cyan spheres indicate hydrophobic interactions, red spheres hydro-
gen-bond acceptor interactions, and blue spheres hydrogen-bond donor
interactions. (a) The hydrophobic pocket of actin. Kabiramide A (blue) and
reidispongiolide A (yellow) are shown for reference. Key: A— hydrophobic
interaction at Gly-23; B — hydrophobic interaction at Ser-141, Ala-144,
Pro-332, Ser-338; C— hydrogen-bond acceptor interaction with Arg-147; D
hydrogen-bond donor interaction with Glu-334; E — hydrogen-bond donor
interaction with Asp-25. (b) The hydrophobic cleft of actin. Bistramide A
(green), kabiramide A (blue), and reidispongiolide A (yellow) are shown for
reference. Key: F — hydrophobic interaction with Arg-147 and Thr-148;
G— hydrophobic interaction with Tyr-143 and Leu-346; H— hydrophobic
interaction with Thr-351; I — hydrophobic interaction with Ile-135, Val-
139, Tyr-169; J — hydrogen-bond acceptor interaction with Thr-351; K —
hydrogen-bond acceptor interaction with Tyr-169. (c) The far end of the
hydrophobic cleft of actin. Bistramide A is shown for reference. Key: L —
hydrophobic interaction with Tyr-133 and Val-370; M — hydrophobic
interaction with Val-134; N — hydrophobic interaction with Leu-110, Asn-
111. (d) Cartoon representation of actin, with kabiramide C in its binding site
at the top of the panel.
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interaction that outweighs the electrostatic interaction by
nearly an order of magnitude according to the AutoDock
scoring function. That these interactions are possibly valid
sites for compounds based on bistramide A is demonstrated
by the highest scoring ﬂexibly docked structure, where the
C12-C13 rotates the enone and pyran group so they occupy
interaction sites M and L. As Kozmin and co-workers iden-
tiﬁed three polar contacts mediated by water molecules (14),
which we have not modeled in our docking study, we can
expect that some deviation from the x-ray structure will occur
to compensate for these missing interactions. Although we
found a hydrogen-bonding interaction near Tyr-169, this is
likely to be occupied by solvent; an analysis of the x-ray struc-
ture of 2FXU reveals a water molecule close to that position.
To illustrate the potential use of these interaction maps, we
modiﬁed the structure of kabiramide C in silico to produce a
ligand that bound more ‘‘efﬁciently’’ (i.e., the docking score
per heavy atomwas larger) than the original structure. We did
not consider synthetic feasibility, nor entropic penalties; we
merely wished to demonstrate that the kabiramide C scaffold
can be reduced without reducing its binding energy substan-
tially and a small number of targeted elaborations can further
improve the strength of binding. From an examination of Fig.
3, we ﬁrst concentrated on the hydrophobic pocket, where the
macrocycle of kabiramide C binds, and targeted the hydro-
phobic interaction at Pro-332 (marked as interaction B in Fig.
3 a), where the lactone of reidispongiolide A is located. To
achieve this we replaced the methyl group at C8 with a pent-
2-enyl group. Additionally, hydrophobic interaction site H in
Fig. 3 b was identiﬁed as a further interaction in the hydro-
phobic cleft. Here we made a modiﬁcation at C32, replacing
the methoxy group with a propoxy group to increase contact
with Thr-351. Elsewhere we identiﬁed a portion of the ring of
kabiramide C as contributing only weakly to the activity. We
experimented with deleting portions of the ring, including
one of the trisoxazole rings, and some pendant groups to the
main scaffold where our analysis had not indicated any
critically important interactions. The deletions and additions
to the main scaffold of kabiramide C are marked by stars and
squares, respectively, in Fig. 4.
Repeating the docking, which allowed ﬂexibility to the
newly added groups, successfully placed them at the targeted
interactions. Thus, we increased the best docking score by
3.2 kcal/mol over kabiramide C, an increase of 20% and a
decrease in Ki of two orders of magnitude, although this
neglects the inﬂuence of entropy and the inherent error in the
AutoDock scoring function (on the order of 2 kcal/mol). At
the same time, the molecular mass has been reduced from
943 Da in kabiramide C to 748 Da, a reduction of 20%.
Although this is still larger than the value recommended in
Lipinski’s famous Rule of Five (35) for maximizing the
probability of oral bioavailability of a molecules (the
threshold is 500), this is clearly a step in the right direction.
This demonstrates the ability of our method to indicate the
important regions for binding. Clearly, there is substantial
scope for development of ligands that bind to actin. The
addition of the propoxy group was also of interest, because
ulapualide A has an acetate substitution here and it had been
considered that this was the cause of the disorder observed in
the tail portion of ulapualide A (10). We observed that the
addition of an acetate group to kabiramide C reduced the
docking score compared to just the alkyl chain, even though
the carbon atoms were placed in equivalent positions. This
effect could be traced to unfavorable steric interaction
between the carbonyl oxygen atom and the sulfur atom of
Met-355. This observation provides some support for the
hypothesis that the acetate group is the cause of the disorder
in ulapualide A.
DISCUSSION
We conclude that ﬂexible docking of ligand fragments is a
valuable tool to rationalize and unify structural data across
several ligands. Docking-based interaction maps provide a
simple visual conﬁrmation of several observations made
from examination of individual or small numbers of x-ray
structures, as well as extending the analysis to potential
interaction sites yet to be exploited. To some extent,
structural bioinformatics tools such as LPC/CSU (ligand-
protein contacts and contacts of structural units) (36) can
reveal similar insights by analyzing ligand-protein atom
contacts to highlight regions of particular complementarity
or, conversely, regions where there is scope to increase the
degree of burial or change the type of interaction. However,
this analysis cannot be combined across several ligands and
visualized as easily as the docking-based method outlined
here. A docking solution also explicitly accounts for confor-
mational effects of modifying the ligand (albeit accounting
for protein ﬂexibility remains challenging) and can also in-
dicate promising regions of the binding site where no ligand
has hitherto been observed to occupy. For actin in particular,
we have been able to focus on a small number of residues,
such as the hydrophobic interaction between the trisoxazole
ring of the kabiramide C and related compounds at Gly-23,
and the hydrophobic interaction between the macrolactone
FIGURE 4 Modiﬁed structure of kabiramide C to probe identiﬁed inter-
actions in the actin binding site. Parts of the structure marked with stars were
deleted; parts marked with squares were added.
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ring of reidispongiolide A at Pro-332. This provides impetus
for future synthetic work, to target those structural features
that are most vital for binding, and represents the ﬁrst steps to
a pharmacophore for the actin binding site.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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